Pinnacle Wealth Management Advisory Group’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$248K Hold
1,864
– – 0.01% 472
2026
Q1
$208K Buy
+1,864
New +$221K 0.01% 510

Other funds holding ABVX

Pinnacle Wealth Management Advisory Group's ABVX Position: Q2 2026 in Review

Pinnacle Wealth Management Advisory Group held its Abivax (ABVX) position steady in Q2 2026 at 1,864 shares worth $248K. The position accounts for 0.01% of the portfolio, ranked #472.

Pinnacle Wealth Management Advisory Group first reported a position in ABVX in Q1 2026 and has held it in 2 quarters since. 304 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Pinnacle Wealth Management Advisory Group held 1,864 shares of Abivax worth $248K as of Q2 2026.
  • Pinnacle Wealth Management Advisory Group left its Abivax share count unchanged in Q2 2026.
  • Abivax made up 0.01% of Pinnacle Wealth Management Advisory Group's portfolio in Q2 2026, its #472 holding.
  • Pinnacle Wealth Management Advisory Group first reported a position in Abivax in Q1 2026 and has held it in 2 quarters since.
  • 304 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q2 2026, filed 5 Aug 2026.